Methodology

All entries for: Sartar Therapeutics Oy

July 22, 2025

Sartar Therapeutics Oy

Orphan Drug Designation

FDA orphan drug designation: treatment of soft tissue sarcomas

Disease Area: Rare Diseases
Source
Source
Scroll to Top